Find Funding Opportunities

NIH Extramural Response to Natural Disasters and Other Emergencies

In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee.  Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.

 COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

Displaying 1231 - 1240 of 2516 Closed Funding Opportunities
Multidisciplinary Studies of HIV/AIDS and Aging (R21)
Expiration Date: Viernes, Junio 23, 2017
NOFO Number: PAR-15-282
Jueves, Junio 18, 2015
Notice Type: PAR
This FOA invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.
NINDS Exploratory Clinical Trials for Small Business (R44)
Expiration Date: Jueves, Enero 11, 2018
NOFO Number: PAR-15-277
Lunes, Junio 15, 2015
Notice Type: PAR
The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
NINDS Exploratory Clinical Trials for Small Business (R42)
Expiration Date: Jueves, Enero 11, 2018
NOFO Number: PAR-15-278
Lunes, Junio 15, 2015
Notice Type: PAR
The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application.
PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Expiration Date: Miércoles, Abril 6, 2016
NOFO Number: PA-15-269
Jueves, Junio 4, 2015
Notice Type: PA
This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the Administration for Children and Families (ACF) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, FDA or ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2015-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, FDA and ACF.
PHS 2015-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Expiration Date: Miércoles, Abril 6, 2016
NOFO Number: PA-15-270
Jueves, Junio 4, 2015
Notice Type: PA
This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics.
Martin Delaney Collaboratories for HIV Cure Research (UM1)
Expiration Date: Martes, Diciembre 8, 2015
NOFO Number: RFA-AI-15-029
Jueves, Mayo 21, 2015
Notice Type: RFA
The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in HIV-infected persons treated with suppressive antiretroviral drug regimens.This FOA will support coordinated basic, translational, and clinical research focused on developing strategies to achieve an HIV cure, defined as sustained HIV remission and/or eradication.The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into clinical studies.Collaboratory research should be milestone-based and centered on specific innovative approaches spanning characterization and quantification of latent or persistent HIV-1 reservoirs, identification of therapeutic strategies that target these reservoirs and/or control viral rebound, and preclinical and clinical studies to test new single or combination strategies for an HIV cure.
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01)
Expiration Date: Martes, Mayo 10, 2016
NOFO Number: PAR-15-257
Jueves, Mayo 14, 2015
Notice Type: PAR
The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research K01 is to diversify the pool of independent neuroscience research investigators and to enhance the opportunity to obtain independent NIH or other independent research support by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of award.
NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)
Expiration Date: Sábado, Julio 18, 2015
NOFO Number: PA-15-249
Miércoles, Mayo 6, 2015
Notice Type: PA
The National Library of Medicine, in conjunction with NIH Institutes and Centers (ICs) named above, announces an Administrative Supplement opportunity available to eligible NIH awardees with active R01 grants and, in some cases, with the other active awards with the activity codes listed above. (see IC-specific details in the Activity Code section above).
Neuroimaging Informatics Tools and Resources Clearinghouse (U24)
Expiration Date: Miércoles, Julio 15, 2015
NOFO Number: RFA-EB-15-005
Miércoles, Mayo 6, 2015
Notice Type: RFA
The purpose of this FOA is to support the Neuroimaging Informatics Tools and Resources Clearinghouse and to enable collaborative research in neuroimaging informatics
NeuroNEXT Infrastructure Resource Access (X01)
Expiration Date: Miércoles, Enero 24, 2018
NOFO Number: PAR-15-195
Jueves, Abril 30, 2015
Notice Type: PAR
This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.
Export to:
A maximum of 400 records can be exported.